Clinical Trials Directory

Trials / Completed

CompletedNCT00004326

Hippocampal Complex Volume and Memory Dysfunction in Cushing's Syndrome

Status
Completed
Phase
Study type
Observational
Enrollment
12 (planned)
Sponsor
National Center for Research Resources (NCRR) · NIH
Sex
All
Age
15 Years – 80 Years
Healthy volunteers
Not accepted

Summary

OBJECTIVES: I. Evaluate whether chronic hypercortisolemia is specifically toxic to hippocampal cells and causes structural reduction of hippocampal volume in patients with Cushing's syndrome. II. Determine whether reduced hippocampal volume is associated with specific memory dysfunction. III. Examine the relationships of adrenal androgen to hippocampal volume and memory dysfunction. IV. Examine the reversibility of hippocampal structural changes and cognitive dysfunction after cortisol levels are normalized.

Detailed description

PROTOCOL OUTLINE: Patients undergo a psychiatric evaluation for mood and cognition during confirmation of diagnosis. Neuropsychologic exams include pencil and paper test and a cognitive assessment. Endocrine studies include dexamethasone and corticotropin-releasing hormone stimulation tests. The hippocampal complex volume is assessed with coronal magnetic resonance imaging. There is a follow-up 1 year after the initiation of treatment.

Conditions

Timeline

Start date
1994-08-01
First posted
1999-10-19
Last updated
2005-06-24

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00004326. Inclusion in this directory is not an endorsement.

Hippocampal Complex Volume and Memory Dysfunction in Cushing's Syndrome (NCT00004326) · Clinical Trials Directory